CardioDynamics (San Diego, California), developer of Impedance Cardiography (ICG) technology and manufacturer of BioZ noninvasive digital cardiac function monitoring systems, said the results of two ICG clinical studies were presented at the late-September annual scientific meeting of the Heart Failure Society of America (HFSA; St. Paul, Minnesota) in Boca Raton, Florida.